These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 32842338)

  • 21. [Effects of intravenous methylprednisolone pulse therapy on optic neuritis associated with AQP4 antibody seropositive neuromyelitis optica].
    Guo ST; Li Z; Jiang LB; Wu RH; Peng JT; Wang JW; Wei WB
    Zhonghua Yan Ke Za Zhi; 2019 Mar; 55(3):180-185. PubMed ID: 30841684
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuromyelitis optica spectrum disorder in China: Quality of life and medical care experience.
    Huang W; ZhangBao J; Chang X; Wang L; Zhao C; Lu J; Wang M; Ding X; Xu Y; Zhou L; Li D; Behne MK; Behne JM; Yeaman MR; Katz E; Lu C; Quan C;
    Mult Scler Relat Disord; 2020 Nov; 46():102542. PubMed ID: 33296965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optic chiasm measurements may be useful markers of anterior optic pathway degeneration in neuromyelitis optica spectrum disorders.
    Juenger V; Cooper G; Chien C; Chikermane M; Oertel FC; Zimmermann H; Ruprecht K; Jarius S; Siebert N; Kuchling J; Papadopoulou A; Asseyer S; Bellmann-Strobl J; Paul F; Brandt AU; Scheel M
    Eur Radiol; 2020 Sep; 30(9):5048-5058. PubMed ID: 32335748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of intravenous methylprednisolone pulse therapy on recurrent optic neuritis associated with aquaporin 4 antibody seropositive neuromyelitis optica].
    Guo ST; Li Z; Jiang LB; Wu RH; Peng JT; Wang JW; Wei WB
    Zhonghua Yan Ke Za Zhi; 2020 Jul; 56(7):509-513. PubMed ID: 32842332
    [No Abstract]   [Full Text] [Related]  

  • 25. Optic neuritis: current challenges in diagnosis and management.
    Benard-Seguin E; Costello F
    Curr Opin Neurol; 2023 Feb; 36(1):10-18. PubMed ID: 36630210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent optic neuritis in a patient with Sjogren syndrome and neuromyelitis optica spectrum disorder: A case report.
    Zheng W; Liu X; Hou X; Zhu Y; Zhang T; Liao L
    Medicine (Baltimore); 2020 Nov; 99(45):e23029. PubMed ID: 33157952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Treatment of Acute Optic Neuritis.
    Keyhanian K; Chwalisz BK
    Semin Ophthalmol; 2023 Aug; 38(6):511-514. PubMed ID: 37162276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of plasma exchange for the treatment of optic neuritis in neuromyelitis optica spectrum disorders: A protocol for systematic review and meta-analysis.
    Han M; Chen Y; Nong L; Liu Z; Hao L; Wang Z
    Medicine (Baltimore); 2020 Jul; 99(28):e21067. PubMed ID: 32664124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visual impairment in neuromyelitis optica spectrum disorders (NMOSD).
    Wu Y; Zhong L; Geng J
    J Chem Neuroanat; 2019 Apr; 97():66-70. PubMed ID: 30716473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chiasmitis Secondary to Neuromyelitis Optica 25 Years After Initial Optic Neuritis.
    Wang R; Kini A; Al Othman B; Lee AG
    J Neuroophthalmol; 2019 Dec; 39(4):515-517. PubMed ID: 31453916
    [No Abstract]   [Full Text] [Related]  

  • 31. A comprehensive review of the advances in neuromyelitis optica spectrum disorder.
    Siriratnam P; Huda S; Butzkueven H; van der Walt A; Jokubaitis V; Monif M
    Autoimmun Rev; 2023 Dec; 22(12):103465. PubMed ID: 37852514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical analysis of neuromyelitis optica spectrum disorders in childhood].
    Zhou J; Zhang Y; Ji TY; Jin YW; Bao XH; Zhang YH; Xiong H; Chang XZ; Jiang YW; Wu Y
    Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):118-124. PubMed ID: 30695886
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations.
    Sahraian MA; Moghadasi AN; Azimi AR; Asgari N; H Akhoundi F; Abolfazli R; Alaie S; Ashtari F; Ayromlou H; Baghbanian SM; Moghadam NB; Fatehi F; Foroughipour M; Langroodi HG; Majdinasab N; Nickseresht A; Nourian A; Shaygannejad V; Torabi HR
    Mult Scler Relat Disord; 2017 Nov; 18():144-151. PubMed ID: 29141797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuromyelitis optica spectrum disorders.
    Huda S; Whittam D; Bhojak M; Chamberlain J; Noonan C; Jacob A
    Clin Med (Lond); 2019 Mar; 19(2):169-176. PubMed ID: 30872305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of aquaporin 4 antibody in the injury of retinal microstructure in neuromyelitis optica spectrum disorders].
    Wang ZW; Wang QQ; Diao DW; Guo QF; Qi XK
    Zhonghua Nei Ke Za Zhi; 2018 Jun; 57(6):435-439. PubMed ID: 29925129
    [No Abstract]   [Full Text] [Related]  

  • 37. [Epidemiology of neuromyelitis optica spectrum disorder].
    Sherman MA; Boyko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(7. Vyp. 2):5-12. PubMed ID: 34387440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
    Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: Case series and review of the literature.
    Aungsumart S; Apiwattanakul M
    Mult Scler Relat Disord; 2017 Apr; 13():93-97. PubMed ID: 28427710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing evolvement of visual field defect in neuromyelitis optica spectrum disorder-optic neuritis and idiopathic optic neuritis: a prospective study.
    Liang J; Zhang Y; Liu K; Xu X; Zhao X; Qiu W; Zhang X; Yang H
    BMC Ophthalmol; 2022 Aug; 22(1):338. PubMed ID: 35945524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.